Project Report For Medical Shop

It is predicted that the India’s pharmaceutical market would increase by three times in the next ten years.

Project Report Sample

Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.

Create 100% Bankable Project Report

Why Choose Us?

Made By Experts

To ensure accuracy, all of our reports is written by industry experts with at least a decade of experience healthcare sector.

Accepted by all Indian Banks

All financial institutions in India acknowledge and trust on the quality of our Project reports.

Hand Made

Our reports are prepared by professionals as those generated by software could land you in legal problems or prevent you from obtaining a business loan.

Purpose Oriented

We recognise that everyone’s goals are unique, which is why we provide customised reports which are tailored to your desired expectations.


The project report for medical shop is as follows.

Consumer spending on medical services was only 8 percent of total consumer spending two decades ago; now, it is 20 percent. Customers are getting more aware with the many commodities in the pharmaceutical business and are looking for high-quality medical treatment.

Mercury has hit an all-time high in terms of the health-care concerns of Indian customers today. Health-care costs are much more than the amount a person spends on clothing or recreational activities.

It is projected that pharmacy shopping would become more organised and corporate in the coming years. The retail pharmacy industry in India is widely scattered throughout the country and the world. Over the past several years, the whole Indian pharmacy chain business has risen at an average pace of 18 percent each year, and it is likely to continue to grow at even greater rates in the future.

Market potential & Strategy

India is the world’s top supplier of generic pharmaceuticals. The Indian pharmaceutical industry fulfills more than half of the world’s demand for different vaccinations, 40 percent of generic demand in the United States, and 25 percent of all medication used in the United Kingdom.

Worldwide, India ranks third in terms of pharmaceutical production volume and fourteenth in respect of pharmaceutical production value. Approximately 10,500 production units are located throughout the country’s pharmaceutical sector, which comprises a network of 3,000 pharmaceuticals businesses.

Currently, India holds a significant role in the global medicines industry. A significant pool of scientists and engineers exists in the nation, with the ability to propel the sector forward to even higher levels of achievement. At the moment, Indian pharmaceutical companies supply more than 80 percent of the antiretroviral medications needed to fight AIDS (Acquired Immune Deficiency Syndrome) throughout the world.

Several studies, including the Indian Economic Survey 2021, predict that the home market will rise threefold during the next ten years. The domestic pharmaceutical industry in India is anticipated to be worth US$ 42 billion in 2021 and to grow to US$ 65 billion by 2024, with additional growth expected to bring the market to US$ 120-130 billion by 2030.

There are several sub-sectors in India’s biotechnology business: biopharmaceutical products and services; biological agriculture; biological industries; and biological information technology (bioinformatics). In 2019, the Indian biotechnology business was valued at US$ 64 billion, with projections indicating that it will grow to US$ 150 billion by 2025.

In fiscal year 2020, the Indian medical equipment market had a value of US$ 10.36 billion. From 2020 to 2025, the market is predicted to grow at a compound annual growth rate (CAGR) of 37 percent, reaching US$ 50 billion.

The pharmaceutical industry in India is expected to grow at an annual pace of 11 percent in the next 2 years, reaching a total value of more than US$ 60 billion by August 2021, according to CARE Ratings Inc.

India is a prominent and rapidly expanding competitor in the international pharmaceutical industry. Currently, India is the world’s largest provider of generic pharmaceuticals, providing approximately 20 percent of global supply by volume and meeting over 60 percent of global immunisation requirement. The Indian pharmaceutical industry is valued at US$ 42 billion and ranks third in terms of quantity and thirteenth in terms of value in the world.

The Indian pharmaceutical industry grew at a rate of 17.7 percent per year in August 2021, up from a rate of 13.7 percent per year in July 2020.